Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 607939, 6 pages
http://dx.doi.org/10.1155/2013/607939
Review Article

Estrogens as Antioxidant Modulators in Human Fertility

1Division of Endocrinology, Department of Internal Medicine, Catholic University of the Sacred Heart, Rome, Italy
2Institute of Biochemistry and Clinical Biochemistry, Catholic University of the Sacred Heart, Rome, Italy

Received 23 April 2013; Revised 28 October 2013; Accepted 28 October 2013

Academic Editor: Maria L. Dufau

Copyright © 2013 A. Mancini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Halliwell and J. M. C. Gutteridge, Free Radical in Biology and Medicine, Clarendon Press, Oxford, UK, 2nd edition, 1979.
  2. G. P. Littarru, Energy and Defence, CESI, Roma, Italy, 1994.
  3. D. Kang and N. Hamasaki, “Mitochondrial oxidative stress and mitochondrial DNA,” Clinical Chemistry and Laboratory Medicine, vol. 41, no. 10, pp. 1281–1288, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. Lancaster, “Nitric oxide in cells,” American Scientist, vol. 80, pp. 249–259, 1992. View at Google Scholar
  5. J. F. Turrens and A. Boveris, “Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria,” Biochemical Journal, vol. 191, no. 2, pp. 421–427, 1980. View at Google Scholar · View at Scopus
  6. A. R. Cross and O. T. G. Jones, “Enzymic mechanism of superoxyde production,” Biochimica et Biophysica Acta, vol. 1057, pp. 281–284, 1991. View at Google Scholar
  7. S. P. Wolff, Z. Y. Jiang, and J. V. Hunt, “Protein glycation and oxidative stress in diabetes mellitus and ageing,” Free Radical Biology and Medicine, vol. 10, no. 5, pp. 339–352, 1991. View at Publisher · View at Google Scholar · View at Scopus
  8. S. E. M. Lewis, P. M. Boyle, K. A. McKinney, I. S. Young, and W. Thompson, “Total antioxidant capacity of seminal plasma is different in fertile and infertile men,” Fertility and Sterility, vol. 64, no. 4, pp. 868–870, 1995. View at Google Scholar · View at Scopus
  9. C. Rice-Evans and N. J. Miller, “Total antioxidant status in plasma and body fluids,” Methods in Enzymology, vol. 234, pp. 279–293, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Meucci, D. Milardi, A. Mordente et al., “Total antioxidant capacity in patients with varicoceles,” Fertility and Sterility, vol. 79, no. 3, pp. 1577–1583, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Agarwal, R. A. Saleh, and M. A. Bedaiwy, “Role of reactive oxygen species in the pathophysiology of human reproduction,” Fertility and Sterility, vol. 79, no. 4, pp. 829–843, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Aktan, S. Dogru-Abbasoglu, C. Kucukgergin, A. Kadioglu, G. Ozdemirler-Erata, and N. Kocak-Toker, “Mystery of idiopathic male infertility: is oxidative stress an actual risk?” Fertility and Sterility, vol. 99, pp. 1211–1215, 2013. View at Google Scholar
  13. M. Shiva, A. K. Gautam, Y. Verma, V. Shivgotra, H. Doshi, and S. Kumar, “Association between sperm quality, oxidative stress, and seminal antioxidant activity,” Clinical Biochemistry, vol. 44, no. 4, pp. 319–324, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Mahfouz, R. Sharma, A. Thiyagarajan et al., “Semen characteristics and sperm DNA fragmentation in infertile men with low and high levels of seminal reactive oxygen species,” Fertility and Sterility, vol. 94, no. 6, pp. 2141–2146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Benedetti, M. C. Tagliamonte, S. Catalani et al., “Differences in blood and semen oxidative status in fertile and infertile men, and their relationship with sperm quality,” Reproductive BioMedicine Online, vol. 25, pp. 300–306, 2012. View at Google Scholar
  16. G. Lavranos, M. Balla, A. Tzortzopoulou, V. Syriou, and R. Angelopoulou, “Investigating ROS sources in male infertility: a common end for numerous pathways,” Reproductive Toxicology, vol. 34, no. 3, pp. 298–307, 2012. View at Publisher · View at Google Scholar
  17. A. Agarwal, A. Singh, A. Hamada, and K. Kesari, “Cell phones and male infertility: a review of recent innovations in technology and consequences,” International Brazilian Journal of Urology, vol. 37, no. 4, pp. 432–454, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Ferramosca, S. P. Provenzano, L. Coppola, and V. Zara, “Mitochondrial respiratory efficiency is positively correlated with human sperm motility,” Urology, vol. 79, no. 4, pp. 809–814, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. H. D. Guthrie, G. R. Welch, and J. A. Long, “Mitochondrial function and reactive oxygen species action in relation to boar motility,” Theriogenology, vol. 70, no. 8, pp. 1209–1215, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Kumar, G. Gautam, and N. P. Gupta, “Drug therapy for idiopathic male infertility: rationale versus evidence,” Journal of Urology, vol. 176, no. 4, pp. 1307–1312, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Felty, W.-C. Xiong, D. Sun et al., “Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers,” Biochemistry, vol. 44, no. 18, pp. 6900–6909, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Borras, J. Gambini, and J. Vina, “Mitochondrial oxidant generation is involved in determining why females live longer than males,” Frontiers in Bioscience, vol. 12, no. 3, pp. 1008–1013, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Vina, C. Borras, M.-C. Gomez-Cabrera, and W. C. Orr, “Part of the series: from dietary antioxidants to regulators in cellular signalling and gene expression. Role of reactive oxygen species and (phyto)oestrogens in the modulation of adaptive response to stress,” Free Radical Research, vol. 40, no. 2, pp. 111–119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. A. J. Schmidt, J.-C. Krieg, and H. Vedder, “Differential effects of glucocorticoids and gonadal steroids on glutathione levels in neuronal and glial cell systems,” Journal of Neuroscience Research, vol. 67, no. 4, pp. 544–550, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Lacort, A. M. Leal, M. Liza, C. Martin, R. Martinez, and M. B. Ruiz-Larrea, “Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro,” Lipids, vol. 30, no. 2, pp. 141–146, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. A. M. Leal, M. B. Ruiz-Larrea, R. Martínez, and M. Lacort, “Cytoprotective actions of estrogens against tert-butyl hydroperoxide-induced toxicity in hepatocytes,” Biochemical Pharmacology, vol. 56, no. 11, pp. 1463–1469, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. J.-F. Arnal, V. Douin-Echinard, F. Tremollières et al., “Understanding the controversy about hormonal replacement therapy: insights from estrogen effects on experimental and clinical atherosclerosis,” Archives des Maladies du Coeur et des Vaisseaux, vol. 100, no. 6-7, pp. 554–562, 2007. View at Google Scholar · View at Scopus
  28. J. P. Buyon, H. M. Korchak, and L. E. Rutherford, “Female hormones reduce neutrophil responsiveness in vitro,” Arthritis and Rheumatism, vol. 27, no. 6, pp. 623–630, 1984. View at Google Scholar · View at Scopus
  29. G. Békési, R. Kakucs, S. Várbíró et al., “In vitro effects of different steroid hormones on superoxide anion production of human neutrophil granulocytes,” Steroids, vol. 65, no. 12, pp. 889–894, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Cemeli, T. E. Schmid, and D. Anderson, “Modulation by flavonoids of DNA damage induced by estrogen-like compounds,” Environmental and Molecular Mutagenesis, vol. 44, no. 5, pp. 420–426, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. M. A. Gómez-Zubeldia, R. Hernandez, J. Viguera, J. J. Arbues, A. Aparicio, and J. C. Millán, “Effect of bilateral ovariectomy and ovarian steroid hormones on the antioxidant systems and plasma malondialdehyde levels in Wistar rats,” Endocrine Research, vol. 26, no. 1, pp. 97–107, 2000. View at Google Scholar · View at Scopus
  32. K. H. Al-Gubory, P. Bolifraud, and C. Garrel, “Regulation of key antioxidant enzymatic systems in the sheep endometrium by ovarian steroids,” Endocrinology, vol. 149, no. 9, pp. 4428–4434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. Y.-M. Lee, P.-Y. Cheng, S.-F. Hong et al., “Oxidative stress induces vascular heme oxygenase-1 expression in ovariectomized rats,” Free Radical Biology and Medicine, vol. 39, no. 1, pp. 108–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Joswig, V. Hach-Wunderle, R. Ziegler, and P. P. Nawroth, “Postmenopausal hormone replacement therapy and the vascular wall: mechanisms of 17 β-estradiol's effects on vascular biology,” Experimental and Clinical Endocrinology and Diabetes, vol. 107, no. 8, pp. 477–487, 1999. View at Google Scholar · View at Scopus
  35. A. Agarwal and S. S. R. Allamaneni, “Role of free radicals in female reproductive diseases and assisted reproduction,” Reproductive BioMedicine Online, vol. 9, no. 3, pp. 338–347, 2004. View at Google Scholar · View at Scopus
  36. A. Agarwal, S. Gupta, and R. K. Sharma, “Role of oxidative stress in female reproduction,” Reproductive Biology and Endocrinology, vol. 3, article 28, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Massafra, C. De Felice, D. Gioia, and G. Buonocore, “Variations in erythrocyte antioxidant glutathione peroxidase activity during the menstrual cycle,” Clinical Endocrinology, vol. 49, no. 1, pp. 63–67, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Zhao and R. D. Brinton, “Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease,” BMC Neuroscience, vol. 7, article 24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. A. J. Schmidt, J.-C. Krieg, and H. Vedder, “Antioxidative and steroid systems in neurological and psychiatric disorders,” World Journal of Biological Psychiatry, vol. 6, no. 1, pp. 26–35, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Nilsen, “Estradiol and neurodegenerative oxidative stress,” Frontiers in Neuroendocrinology, vol. 29, no. 4, pp. 463–475, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. M. T. R. Subbiah, “Estrogen replacement therapy and cardioprotection: mechanisms and controversies,” Brazilian Journal of Medical and Biological Research, vol. 35, no. 3, pp. 271–276, 2002. View at Google Scholar · View at Scopus
  42. S. Parthasarathy, N. Khan-Merchant, M. Penumetcha, and N. Santanam, “Oxidative stress in cardiovascular disease,” Journal of Nuclear Cardiology, vol. 8, no. 3, pp. 379–389, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. J.-F. Louet, C. LeMay, and F. Mauvais-Jarvis, “Antidiabetic actions of estrogen: insight from human and genetic mouse models,” Current Atherosclerosis Reports, vol. 6, no. 3, pp. 180–185, 2004. View at Google Scholar · View at Scopus
  44. X. Zhu, B. Bonet, H. Gillenwater, and R. H. Knopp, “Opposing effects of estrogen and progestins on LDL oxidation and vascular wall cytotoxicity: implications for atherogenesis,” Proceedings of the Society for Experimental Biology and Medicine, vol. 222, no. 3, pp. 214–221, 1999. View at Google Scholar · View at Scopus
  45. H. Wiseman and J. O'Reilly, “The cardioprotective antioxidant activity of dietary phytoestrogens compared to oestrogen,” Biochemical Society Transactions, vol. 25, no. 1, p. 107, 1997. View at Google Scholar · View at Scopus
  46. F. Comhaire, “Treatment of oligospermia with tamoxifen,” International Journal of Fertility, vol. 21, no. 4, pp. 232–238, 1976. View at Google Scholar · View at Scopus
  47. I.-G. Kotoulas, E. Cardamakis, J. Michopoulos, D. Mitropoulos, and A. Dounis, “Tamoxifen treatment in male infertility. I. Effect on spermatozoa,” Fertility and Sterility, vol. 61, no. 5, pp. 911–914, 1994. View at Google Scholar · View at Scopus
  48. J. Buvat, K. Ardaens, and A. Lemaire, “Increased sperm count in 25 cases of idiopathic normogonadotropic oligospermia following treatment with tamoxifen,” Fertility and Sterility, vol. 39, no. 5, pp. 700–703, 1983. View at Google Scholar · View at Scopus
  49. W. B. Schill and M. Landthaler, “Tamoxifen treatment of oligozoospermia,” Andrologia, vol. 12, no. 6, pp. 546–548, 1980. View at Google Scholar · View at Scopus
  50. J. M. J. Dony, A. G. H. Smals, and R. Rolland, “Effect of lower versus higher doses of tamoxifen on pituitary-gonadal function and sperm indices in oligozoospermic men,” Andrologia, vol. 17, no. 4, pp. 369–378, 1985. View at Google Scholar · View at Scopus
  51. E. Tsourdi, A. Kourtis, D. Farmakiotis, I. Katsikis, M. Salmas, and D. Panidis, “The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia,” Fertility and Sterility, vol. 91, no. 4, pp. 1427–1430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Vandekerckhove, R. Lilford, A. Vail, and E. Hughes, “WITHDRAWN: clomiphene or tamoxifen for idiopathic oligo/asthenospermia,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD000151, 2007. View at Google Scholar · View at Scopus
  53. World Health Organization, “A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertilit,” International Journal of Andrology, vol. 15, no. 4, pp. 299–307, 1992. View at Google Scholar
  54. A. Kamischke and E. Nieschlag, “Analysis of medical treatment of male infertility,” Human Reproduction, vol. 14, no. 1, pp. 1–23, 1999. View at Publisher · View at Google Scholar · View at Scopus
  55. M. E. Chua, K. G. Escusa, S. Luna, L. C. Tapia, B. Dofitas, and M. Morales, “Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta-analysis,” Andrology, vol. 1, pp. 749–757, 2013. View at Google Scholar
  56. E. Koukkou, E. Billa, N. Kapolla et al., “An empiric treatment for idiopathic oligozoospermia revisited: a 20-year investigative saga,” Andrologia, vol. 44, pp. 337–342, 2012. View at Google Scholar
  57. T. C. Kadioglu, “Oral tamoxifen citrate treatment is more effective in normogonadotropic patients who have follicle-stimulating hormone levels within the lower half of normal,” International Urology and Nephrology, vol. 41, no. 4, pp. 773–776, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. K.-F. Tang, Y. Xing, C.-Y. Wu, R.-Z. Liu, X.-Y. Wang, and J.-P. Xing, “Tamoxifen combined with coenzyme Q10 for idiopathic oligoasthenospermia,” Zhonghua Nan Ke Xue, vol. 17, no. 7, pp. 615–618, 2011. View at Google Scholar · View at Scopus
  59. G. Balercia, F. Mosca, F. Mantero et al., “Coenzyme Q10 supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study,” Fertility and Sterility, vol. 81, no. 1, pp. 93–98, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. G. Balercia, E. Buldreghini, A. Vignini et al., “Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial,” Fertility and Sterility, vol. 91, no. 5, pp. 1785–1792, 2009. View at Publisher · View at Google Scholar
  61. A. Mancini, D. Milardi, E. Meucci et al., “Coenzyme Q10 effects on non-enzymatic total antioxidant capacity in seminal plasma of varicocele patients,” in International Congress Series 1271, pp. 215–218,, Elsevier B.V., Amsterdam, The Netherlands, 2004. View at Google Scholar
  62. A. Mancini, L. De Marinis, G. P. Littarru, and G. Balercia, “An update of Coenzyme Q10 implications in male infertility: biochemical and therapeutic aspects,” BioFactors, vol. 25, no. 1–4, pp. 165–174, 2005. View at Google Scholar · View at Scopus